Name: Colistimethate Sodium (2 Million IU) – Clickstin 2MIU Injection
Brand: Clickstin 2MIU Injection
Rating: 4.8 (150 reviews)

Home/Products /colistimethate-sodium-2-million-iu-injection

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Colistimethate Sodium (2 Million IU) Injection at the best price in PCD Pharma Franchise for Antibiotic, Bacterial Infections.

Colistimethate Sodium (2 Million IU) Injection at the best price in Pharma Manufacturers in India for Antibiotic, Bacterial Infections.

Colistimethate Sodium (2 Million IU) Injection at the best price in German Pharmaceutical Export Company for Antibiotic, Bacterial Infections.

Colistimethate Sodium (2 Million IU) Injection at the best price in Top Drug Companies for Antibiotic, Bacterial Infections.

Clickstin 2MIU Injection at the best price in Antibiotic Pharma Franchise.

Clickstin 2MIU Injection

Composition : Colistimethate Sodium (2Million IU)

Dosage Form : Injection

Packaging Type : W.F.I. + Tray

Packaging : Vial

Price : ₹2790/-

Please Contact For Best Price

Clickstin 2MIU Injection contains Colistimethate Sodium (2 Million IU), an advanced antibiotic designed for the treatment of severe infections caused by multidrug-resistant Gram-negative bacteria. It is primarily used in critically ill patients to manage infections such as pneumonia, bloodstream infections, urinary tract infections, and intra-abdominal infections caused by pathogens like Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Colistimethate works by disrupting bacterial cell membranes, effectively halting bacterial growth and preventing further spread.

This injection is reserved for hospital use and is administered under strict medical supervision. It is particularly beneficial in cases where other antibiotics have failed or resistance has developed, ensuring targeted therapy for life-threatening conditions.